Active Ingredient (In Each Tablet)
Sennosides 17.2 mg
The following Structured Product Label (SPL) was submitted to the FDA by Atlantis Consumer Healthcare, Inc. for the product Senokot (NDC 67618-120). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, ask a doctor before use if you have, stop use, pregnancy or breast feeding, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Sennosides 17.2 mg
Laxative
Do not use laxative products for longer than 1 week unless directed by a doctor
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | startingdosage | maximumdosage |
| adults and children 12 yearsof age and over | 1 tablet once a day | 2 tablets twice aday |
| children 6 to under 12 years | ½ tablet once a day | 1 tablet twice aday |
| children under 6 | ask a doctor | ask a doctor |
croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid
Senokot® Extra Strength
36 Tablets Carton
Senokot® Extra Strength
12 Tablets Carton
Senokot® Extra Strength 36 Tablets Label
Senokot®
Standardized Senna Concentrate, 17.2mg
Extra
Strength
Natural vegetable
laxative Ingredient
72 Tablets
DO NOT USE IF SEAL UNDER CAP IS
MISSING OR DAMAGED.
A0725
LOT:
EXP:
R54038
Dist. by: Atlantis Consumer Healthcare Inc.
Bridgewater, NJ 08807 USA
Questions? 1-833-288-2684 www.senokot.com
©2025 Atlantis Consumer Healthcare Inc.
* Please review the disclaimer below.